Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
Massachusetts General Hospital
Massachusetts General Hospital
Indiana University
OHSU Knight Cancer Institute
Dartmouth-Hitchcock Medical Center
Emory University
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Dana-Farber Cancer Institute
Virginia Commonwealth University